• Search

Blog

Can We Model Neuroimmune Diseases in a Dish?

Can We Model Neuroimmune Diseases in a Dish?

Following Axol Bioscience and Censo Biotechnologies recent merger to form Axol Biosciences, our CSO Ashley Barnes was invited to speak at the Neuroimmunology Drug Development Summit alongside other experts from academia and industry on the advances being made in this burgeoning field.

In this article we feature his answers to some of the pressing questions that arose from the audience and the field.